More on KPTI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.1 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Karyopharm Therapeutics (NQ:KPTI)
Delayed: 1.69 -0.03 (1.74%)
Prev. Close $1.72  
Open$1.72 
52 Wk High$19.41 
52 Wk Low$4.83 
Day High$1.75 
Day Low$1.65 
P/E N/A  
EPS$-2.74 
Volume772,568 

Friends, Peers and Foes (?): ARWR, CAPR, CRSP, ALNY, ARVN (more...)

Aug 31, 2026 07:32 AM Karyopharm files sNDA seeking FDA approval for myelofibrosis combo
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2026 04:20 PM Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: Commodore Capital LP
Aug 13, 2026 07:41 AM Form 10-Q Karyopharm Therapeutics For: Jun 30
Aug 13, 2026 07:38 AM Form 8-K Karyopharm Therapeutics For: Aug 13
Aug 13, 2026 07:34 AM Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Aug 13, 2026 07:30 AM Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
Aug 12, 2026 12:04 PM Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: Adage Capital Management, L.P.
Aug 11, 2026 08:54 PM Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: GOLDMAN SACHS GROUP INC
Aug 11, 2026 09:55 AM Increasing unusual call volume: KPTI ACB SHLD ABAT BW PBF UPWK TME TENX BMBL ARMK AS KOPN SES
View All Articles

Entities mentioned with KPTI

View All Entities